]>
IRCT20170821035817N3 IRCT 2019-04-28 Iranian academic center for education culture and research Effect of Trigonella foenum, Vaccinium arctostaphylos, Cichorium intybus, Matricaria chamomilla and Urtica dioica extract mixture in treatment of diabetes. Effect of Trigonella foenum, Vaccinium arctostaphylos, Cichorium intybus, Matricaria chamomilla and Urtica dioica extract mixture on blood sugar control in type 2 diabetic patients. 2019-05-22 anticipated 100 Complete https://irct.ir/trial/38750 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: Based on the include criteria and using the random sampling software, the subjects are divided into two groups of intervention and control. The drugs and placebo are placed in sealed envelopes, Blinding description: Participant-Clinical care- Researcher. 2-3 Diabetes. Intervention 1: Intervention group: Patients in this group receive a 500 mg capsule of herbal drug two times a day. Intervention 2: Control group: Patients in this group receive a 500 mg capsule of placebo two times a day. Yes - There is a plan to make this available What will be shared: There is no further information When: Not decided yet To whom: Not decided yet Conditions: Not decided yet Where to obtain: Not decided yet How to obtain: Not decided yet Comments:
public Zhila Taherzadeh
No.18, Daneshgah ST.
Mashhad Iran (Islamic Republic of) 9138813944 +98 51 3841 2081 TaherzadehZh@mums.ac.ir Mashhad University of Medical Sciences scientific Hasan Fallah Huseini
Research Complex of Jahad Daneshgahi, Kavosh Boulevard, Supa Boulevard, 55th Kilometer of Tehran-Gazvin Freeway, Karaj, Iran.
Karaj Iran (Islamic Republic of) 31375-369 +98 26 3476 4018 huseini_fallah@yahoo.com Iranian academic center for education culture and research Iran (Islamic Republic of) Diabetic patients treated with Dietary and hypoglycemic agents Blood HbA1c level 7.5-8.5 % Fasting blood glucose levels between 130 to 170 mg/dL Have diabetes for at least two years 40 to 60 years old 40 years 60 years Both Patient with renal, hepatic and cardiac failure Patients with diabetic foot ulcer, gangrene, or any severe illness Painful diabetic neuropathy and depressed patients Smokers and alcoholic patients Patients who tend to change their exercise program or diet E11 Type 2 diabetes mellitus Treatment - Drugs Treatment - Drugs Intervention group: Patients in this group receive a 500 mg capsule of herbal drug two times a day. Control group: Patients in this group receive a 500 mg capsule of placebo two times a day. Fasting blood glucose. Timepoint: Baseline and after 3 months at end of the study. Method of measurement: Blood Test. HbA1C. Timepoint: Baseline and after 3 months at end of the study. Method of measurement: Blood Test. Cholesterol. Timepoint: Baseline and after 3 months at end of the study. Method of measurement: Blood Test. Triglycerid. Timepoint: Baseline and after 3 months at end of the study. Method of measurement: Blood Test. Low-density lipoprotein. Timepoint: At starting of the study and after 3 months. Method of measurement: Blood low-density lipoprotein level will be determined in laboratory by commercially available. High-density lipoprotein. Timepoint: At starting of the study and after 3 months. Method of measurement: Blood High-density lipoprotein level will be determined in laboratory by commercially available kit. Aspartate aminotransferase. Timepoint: At starting of the study and after 3 months. Method of measurement: Blood aspartate aminotransferase level will be determined in laboratory by commercially available kit. Alanine aminotransferase. Timepoint: At starting of the study and after 3 months. Method of measurement: Blood alanine aminotransferase level will be determined in laboratory by commercially available kit. Blood urea nitrogen. Timepoint: At starting of the study and after 3 months. Method of measurement: Blood blood urea nitrogen level will be determined in laboratory by commercially available kit. Creatinine. Timepoint: At starting of the study and after 3 months. Method of measurement: Blood creatinine level will be determined in laboratory by commercially available kit. Alkalin phosphatase. Timepoint: At starting of the study and after 3 months. Method of measurement: Blood Alkalin phosphatase level will be determined in laboratory by commercially available kit. Mashhad University of Medical Sciences Iranian academic center for education culture and research Mashhad University of Medical Sciences Approved 2019-01-17 Ethics Committee of Mashhad University of Medical Scienses No.18, Daneshgah St Mashhad Razavi Khorasan Iran (Islamic Republic of)